ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.667,83
0,85%
S&P 500
6.032,38
0,56%
US Dollar vs BRL
5,97435
0,00%
Bitcoin
96.844,56
0,42%
Brent Oil
71,98
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Revvity Inc (RVTY)

  7. Revvity Inc (RVTY) Notícias

RVTY

Revvity (RVTY)

Revvity Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:RVTY
DataHoraFonteTítuloCódigoCompanhia
20/11/202410:00Business WireRevvity Broadens Relationship with Genomics England to Advance Genomics in the UKNYSE:RVTYRevvity Inc
19/11/202410:00Business WireScale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single CellsNYSE:RVTYRevvity Inc
19/11/202410:00Business WireRevvity to Present at 7th Annual Evercore ISI HealthCONx ConferenceNYSE:RVTYRevvity Inc
18/11/202410:00Business WireRevvity to Host Investor Day and Updates Organizational Structure to Reflect Recent TransformationNYSE:RVTYRevvity Inc
14/11/202418:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:RVTYRevvity Inc
14/11/202415:22Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNYSE:RVTYRevvity Inc
06/11/202418:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:RVTYRevvity Inc
04/11/202408:11Edgar (US Regulatory)Form 8-K - Current reportNYSE:RVTYRevvity Inc
04/11/202408:00Business WireRevvity Announces Financial Results for the Third Quarter of 2024NYSE:RVTYRevvity Inc
24/10/202417:05Business WireRevvity Board Declares Quarterly DividendNYSE:RVTYRevvity Inc
22/10/202410:00Business WireRevvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical LaboratoriesNYSE:RVTYRevvity Inc
22/10/202409:00Business WireRevvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact ReportNYSE:RVTYRevvity Inc
10/10/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RVTYRevvity Inc
09/10/202417:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RVTYRevvity Inc
07/10/202418:21Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NYSE:RVTYRevvity Inc
07/10/202409:00Business WireRevvity To Hold Earnings Call on Monday, November 4, 2024NYSE:RVTYRevvity Inc
02/10/202409:00Business WireRevvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE GeneNYSE:RVTYRevvity Inc
21/08/202409:00Business WireRevvity to Present at Upcoming Investor ConferencesNYSE:RVTYRevvity Inc
29/07/202407:00Business WireRevvity Announces Financial Results for the Second Quarter of 2024NYSE:RVTYRevvity Inc
09/07/202409:00Business WireRevvity To Hold Earnings Call on Monday, July 29, 2024NYSE:RVTYRevvity Inc
20/06/202409:00GlobeNewswire Inc.Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing ResearchNYSE:RVTYRevvity Inc
31/05/202409:00Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:RVTYRevvity Inc
28/05/202409:00Business WireRevvity to Present at Goldman Sachs Global Healthcare ConferenceNYSE:RVTYRevvity Inc
29/04/202407:00Business WireRevvity Announces Financial Results for the First Quarter of 2024NYSE:RVTYRevvity Inc
25/04/202409:00Business WireRevvity to Present at BofA Securities 2024 Health Care ConferenceNYSE:RVTYRevvity Inc
24/04/202407:00Business WireRevvity Unveils a New Era of Automated Tuberculosis TestingNYSE:RVTYRevvity Inc
15/04/202407:00Business WireRevvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract PartnersNYSE:RVTYRevvity Inc
04/04/202409:00Business WireRevvity To Hold Earnings Call on Monday, April 29, 2024NYSE:RVTYRevvity Inc
02/04/202407:00Business WirePreliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire SoftwareNYSE:RVTYRevvity Inc
20/03/202418:00Business WireRevvity Files Complaint and Seeks Injunctive Relief Against Cloud Software GroupNYSE:RVTYRevvity Inc
 Apresentando as notícias mais relevantes sobre:NYSE:RVTY

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
OIBR3
OI ON
BOV
ATOM3
ATOMPAR ON
BOV
LUPA3
LUPATECH ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 50%* para TRADER BRASIL

1 ano 30%, 2 anos 40% e *3 anos 50%

*Ao longo de 3 anos $ 881.64 apenas $ 440.82